Statistics

Total Visits

Views
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis61

Select a period of time:

Number of views in the range

Views
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis25

Views

Views
May 20252
June 20250
July 202517
August 20254
September 20252
October 20250
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil12
United States6
Ecuador2
United Kingdom1
Ireland1
Morocco1
Turkey1
Trinidad and Tobago1
 

Top cities views

Views
Belo Horizonte2
Balneário Camboriú1
Birmingham1
Bluffton1
Dallas1
Dublin1
Edwardsville1
Guararema1
Hollywood1
Itanhomi1